Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Perrigo Gets FDA Approval For OTC Miconazole Nitrate Vaginal Cream
Monistat -1 OTC product is indicated for the treatment of vaginal yeast infections and for the relief of external itching and irritation they cause. Perrigo was the first
Monistat -1 OTC product is indicated for the treatment of vaginal yeast infections and for the relief of external itching and irritation they cause. Perrigo was the first
Chiltern will draw upon many parts of TAHSC, including the Clinical Research Centre (CRC) which is located on the same University Medical School and hospital campus as Chiltern
Under the terms of the agreement, Perceptive Imagineering will represent RPC and conduct product registration, marketing, sales and support for the licensing and distribution of Onko-Sure as a
The VitaVasK study will last for three years and will measure placebo controlled effect of high doses of MenaQ7 in some 600 kidney patients over one and a
LAB Research supports the development of its customers’ products from three facilities located in Canada, Denmark and Hungary. GLP compliance of the Canadian laboratory site has been recognized
The new patent is titled ‘Regioselective and Stereoselective Oxidation of Fused Ring Systems Useful for the Preparation of Aminosterols’. It marks the first patent issued for this intellectual
Novella Clinical and Prologue Research have been providing contract research services for biotechnology, pharmaceutical and device companies for 12 years. The acquisition will add approximately 60 staff to
The new, five-building, EUR77m B Braun manufacturing campus includes a plant dedicated to producing infusion pumps as well as facilities for research and development, services and training. With
Everolimus is approved under the trade name Afinitor (everolimus) tablets for the treatment of patients with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or
Scientia Advisors has released a review report titled ‘Assessing the Biopharmaceutical Market: Promises and Challenges.’ According to it the revenue growth for the small molecule drug segment has